H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Genentech USA, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Genentech USA, Inc.
CARank #FEIN 20-5958096

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPGenentech USA, Inc.
Total filings80,813327
Certified %98.23%72.78%
Denied %1.09%0.31%
Withdrawn %0.61%3.67%
Cert-withdrawn %0.07%23.24%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePACA

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Genentech USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 72.8%, Cert-withdrawn 23.2%, Withdrawn 3.7%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified72.8%
Cert-withdrawn23.2%
Withdrawn3.7%
Denied0.3%
Certified72.8%
Cert-withdrawn23.2%
Withdrawn3.7%
Denied0.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Genentech USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY20115
FY20124
FY20138
FY201419
FY201525
FY201639
FY201748
FY201837
FY201947
FY20209
FY20213
FY20223
FY202316
FY202423
FY202522
FY202615

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Genentech USA, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.